nodes	percent_of_prediction	percent_of_DWPC	metapath
Procaine—Probenecid—Tolbutamide—type 2 diabetes mellitus	0.361	0.522	CrCrCtD
Procaine—Probenecid—Chlorpropamide—type 2 diabetes mellitus	0.331	0.478	CrCrCtD
Procaine—BCHE—Ramipril—type 2 diabetes mellitus	0.0844	1	CbGbCtD
Procaine—SCN10A—peripheral nervous system—type 2 diabetes mellitus	0.00153	0.234	CbGeAlD
Procaine—SCN10A—nerve—type 2 diabetes mellitus	0.0012	0.183	CbGeAlD
Procaine—HTR3A—nerve—type 2 diabetes mellitus	0.00111	0.169	CbGeAlD
Procaine—SLC6A3—nerve—type 2 diabetes mellitus	0.000923	0.141	CbGeAlD
Procaine—Procainamide—DNMT1—type 2 diabetes mellitus	0.0008	0.231	CrCbGaD
Procaine—Clomifene—CYP11A1—type 2 diabetes mellitus	0.000789	0.228	CrCbGaD
Procaine—HTR3A—islet of Langerhans—type 2 diabetes mellitus	0.000537	0.0821	CbGeAlD
Procaine—SCN10A—nephron tubule—type 2 diabetes mellitus	0.000467	0.0713	CbGeAlD
Procaine—Probenecid—ABCC2—type 2 diabetes mellitus	0.000386	0.111	CrCbGaD
Procaine—Aminohippurate—ABCC2—type 2 diabetes mellitus	0.00038	0.11	CrCbGaD
Procaine—Clomifene—CYP2E1—type 2 diabetes mellitus	0.000304	0.088	CrCbGaD
Procaine—Clomifene—CYP1A2—type 2 diabetes mellitus	0.00029	0.0837	CrCbGaD
Procaine—Rash—Repaglinide—type 2 diabetes mellitus	0.000274	0.00166	CcSEcCtD
Procaine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000274	0.00166	CcSEcCtD
Procaine—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000274	0.00166	CcSEcCtD
Procaine—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000272	0.00165	CcSEcCtD
Procaine—Shock—Glyburide—type 2 diabetes mellitus	0.000272	0.00165	CcSEcCtD
Procaine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000272	0.00165	CcSEcCtD
Procaine—Sweating increased—Ramipril—type 2 diabetes mellitus	0.000271	0.00165	CcSEcCtD
Procaine—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000271	0.00165	CcSEcCtD
Procaine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000269	0.00163	CcSEcCtD
Procaine—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.000268	0.00162	CcSEcCtD
Procaine—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000267	0.00162	CcSEcCtD
Procaine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000266	0.00162	CcSEcCtD
Procaine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000266	0.00161	CcSEcCtD
Procaine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000265	0.00161	CcSEcCtD
Procaine—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000264	0.0016	CcSEcCtD
Procaine—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000264	0.0016	CcSEcCtD
Procaine—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000263	0.0016	CcSEcCtD
Procaine—Chills—Metformin—type 2 diabetes mellitus	0.000262	0.00159	CcSEcCtD
Procaine—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000261	0.00158	CcSEcCtD
Procaine—Vision blurred—Orlistat—type 2 diabetes mellitus	0.00026	0.00158	CcSEcCtD
Procaine—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000259	0.00157	CcSEcCtD
Procaine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000259	0.00157	CcSEcCtD
Procaine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000259	0.00157	CcSEcCtD
Procaine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000258	0.00157	CcSEcCtD
Procaine—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000258	0.00157	CcSEcCtD
Procaine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000258	0.00157	CcSEcCtD
Procaine—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000257	0.00156	CcSEcCtD
Procaine—Angioedema—Valsartan—type 2 diabetes mellitus	0.000256	0.00155	CcSEcCtD
Procaine—Erythema—Metformin—type 2 diabetes mellitus	0.000255	0.00155	CcSEcCtD
Procaine—Pruritus—Glipizide—type 2 diabetes mellitus	0.000254	0.00154	CcSEcCtD
Procaine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000254	0.00154	CcSEcCtD
Procaine—Angioedema—Orlistat—type 2 diabetes mellitus	0.000252	0.00153	CcSEcCtD
Procaine—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000252	0.00153	CcSEcCtD
Procaine—Syncope—Valsartan—type 2 diabetes mellitus	0.000251	0.00152	CcSEcCtD
Procaine—Chills—Irbesartan—type 2 diabetes mellitus	0.000248	0.0015	CcSEcCtD
Procaine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000247	0.0015	CcSEcCtD
Procaine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000246	0.0015	CcSEcCtD
Procaine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000246	0.00149	CcSEcCtD
Procaine—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000246	0.00149	CcSEcCtD
Procaine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000244	0.00148	CcSEcCtD
Procaine—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.000243	0.00148	CcSEcCtD
Procaine—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000243	0.00148	CcSEcCtD
Procaine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000242	0.00147	CcSEcCtD
Procaine—Tinnitus—Losartan—type 2 diabetes mellitus	0.000242	0.00147	CcSEcCtD
Procaine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00024	0.00146	CcSEcCtD
Procaine—Erythema—Irbesartan—type 2 diabetes mellitus	0.00024	0.00146	CcSEcCtD
Procaine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00024	0.00146	CcSEcCtD
Procaine—BCHE—nephron tubule—type 2 diabetes mellitus	0.00024	0.0367	CbGeAlD
Procaine—Vision blurred—Metformin—type 2 diabetes mellitus	0.00024	0.00146	CcSEcCtD
Procaine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000239	0.00145	CcSEcCtD
Procaine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000239	0.00145	CcSEcCtD
Procaine—Tremor—Metformin—type 2 diabetes mellitus	0.000239	0.00145	CcSEcCtD
Procaine—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000238	0.00145	CcSEcCtD
Procaine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000238	0.00144	CcSEcCtD
Procaine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000237	0.00144	CcSEcCtD
Procaine—Anxiety—Valsartan—type 2 diabetes mellitus	0.000237	0.00144	CcSEcCtD
Procaine—Tension—Irbesartan—type 2 diabetes mellitus	0.000236	0.00143	CcSEcCtD
Procaine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000236	0.00143	CcSEcCtD
Procaine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000234	0.00142	CcSEcCtD
Procaine—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000233	0.00142	CcSEcCtD
Procaine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000232	0.00141	CcSEcCtD
Procaine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00023	0.00139	CcSEcCtD
Procaine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000229	0.00139	CcSEcCtD
Procaine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000229	0.00139	CcSEcCtD
Procaine—Syncope—Metformin—type 2 diabetes mellitus	0.000228	0.00139	CcSEcCtD
Procaine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000228	0.00139	CcSEcCtD
Procaine—Oedema—Valsartan—type 2 diabetes mellitus	0.000228	0.00139	CcSEcCtD
Procaine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000228	0.00138	CcSEcCtD
Procaine—Rash—Glipizide—type 2 diabetes mellitus	0.000227	0.00138	CcSEcCtD
Procaine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000226	0.00138	CcSEcCtD
Procaine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000226	0.00138	CcSEcCtD
Procaine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000226	0.00137	CcSEcCtD
Procaine—Erythema—Losartan—type 2 diabetes mellitus	0.000226	0.00137	CcSEcCtD
Procaine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000226	0.00137	CcSEcCtD
Procaine—Oedema—Orlistat—type 2 diabetes mellitus	0.000226	0.00137	CcSEcCtD
Procaine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000225	0.00137	CcSEcCtD
Procaine—Shock—Valsartan—type 2 diabetes mellitus	0.000225	0.00136	CcSEcCtD
Procaine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000224	0.00136	CcSEcCtD
Procaine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000223	0.00136	CcSEcCtD
Procaine—Tension—Losartan—type 2 diabetes mellitus	0.000222	0.00135	CcSEcCtD
Procaine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000222	0.00135	CcSEcCtD
Procaine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000221	0.00134	CcSEcCtD
Procaine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000221	0.00134	CcSEcCtD
Procaine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000221	0.00134	CcSEcCtD
Procaine—Hypertension—Metformin—type 2 diabetes mellitus	0.00022	0.00134	CcSEcCtD
Procaine—Urticaria—Glyburide—type 2 diabetes mellitus	0.00022	0.00133	CcSEcCtD
Procaine—Nervousness—Losartan—type 2 diabetes mellitus	0.00022	0.00133	CcSEcCtD
Procaine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00022	0.00133	CcSEcCtD
Procaine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000218	0.00132	CcSEcCtD
Procaine—BCHE—cardiovascular system—type 2 diabetes mellitus	0.000216	0.0329	CbGeAlD
Procaine—Syncope—Irbesartan—type 2 diabetes mellitus	0.000216	0.00131	CcSEcCtD
Procaine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000215	0.00131	CcSEcCtD
Procaine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000214	0.0013	CcSEcCtD
Procaine—Nausea—Glipizide—type 2 diabetes mellitus	0.000214	0.0013	CcSEcCtD
Procaine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000213	0.0013	CcSEcCtD
Procaine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000213	0.0013	CcSEcCtD
Procaine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000213	0.00129	CcSEcCtD
Procaine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000213	0.00129	CcSEcCtD
Procaine—Tremor—Losartan—type 2 diabetes mellitus	0.000212	0.00129	CcSEcCtD
Procaine—Rash—Glimepiride—type 2 diabetes mellitus	0.000212	0.00128	CcSEcCtD
Procaine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000211	0.00128	CcSEcCtD
Procaine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000211	0.00128	CcSEcCtD
Procaine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000211	0.00128	CcSEcCtD
Procaine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000211	0.00128	CcSEcCtD
Procaine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000208	0.00126	CcSEcCtD
Procaine—Agitation—Losartan—type 2 diabetes mellitus	0.000208	0.00126	CcSEcCtD
Procaine—Oedema—Metformin—type 2 diabetes mellitus	0.000208	0.00126	CcSEcCtD
Procaine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000208	0.00126	CcSEcCtD
Procaine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000207	0.00126	CcSEcCtD
Procaine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000207	0.00126	CcSEcCtD
Procaine—Angioedema—Losartan—type 2 diabetes mellitus	0.000207	0.00126	CcSEcCtD
Procaine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000205	0.00125	CcSEcCtD
Procaine—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000205	0.00124	CcSEcCtD
Procaine—Shock—Metformin—type 2 diabetes mellitus	0.000204	0.00124	CcSEcCtD
Procaine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000204	0.00124	CcSEcCtD
Procaine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000204	0.00124	CcSEcCtD
Procaine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000203	0.00124	CcSEcCtD
Procaine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000203	0.00123	CcSEcCtD
Procaine—Syncope—Losartan—type 2 diabetes mellitus	0.000203	0.00123	CcSEcCtD
Procaine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000202	0.00123	CcSEcCtD
Procaine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000201	0.00122	CcSEcCtD
Procaine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.0002	0.00122	CcSEcCtD
Procaine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000199	0.00121	CcSEcCtD
Procaine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000199	0.00121	CcSEcCtD
Procaine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000199	0.00121	CcSEcCtD
Procaine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000197	0.0012	CcSEcCtD
Procaine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000197	0.0012	CcSEcCtD
Procaine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000196	0.00119	CcSEcCtD
Procaine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000196	0.00119	CcSEcCtD
Procaine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000196	0.00119	CcSEcCtD
Procaine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000196	0.00119	CcSEcCtD
Procaine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000194	0.00118	CcSEcCtD
Procaine—Hypotension—Metformin—type 2 diabetes mellitus	0.000194	0.00118	CcSEcCtD
Procaine—Erythema—Ramipril—type 2 diabetes mellitus	0.000194	0.00118	CcSEcCtD
Procaine—Shock—Irbesartan—type 2 diabetes mellitus	0.000193	0.00117	CcSEcCtD
Procaine—Arthralgia—Losartan—type 2 diabetes mellitus	0.000193	0.00117	CcSEcCtD
Procaine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000192	0.00117	CcSEcCtD
Procaine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000192	0.00117	CcSEcCtD
Procaine—Anxiety—Losartan—type 2 diabetes mellitus	0.000192	0.00117	CcSEcCtD
Procaine—Clomifene—CYP3A4—type 2 diabetes mellitus	0.000192	0.0554	CrCbGaD
Procaine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000191	0.00116	CcSEcCtD
Procaine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000191	0.00116	CcSEcCtD
Procaine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000191	0.00116	CcSEcCtD
Procaine—Tension—Ramipril—type 2 diabetes mellitus	0.00019	0.00116	CcSEcCtD
Procaine—BCHE—adipose tissue—type 2 diabetes mellitus	0.00019	0.029	CbGeAlD
Procaine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.00019	0.00115	CcSEcCtD
Procaine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000189	0.00115	CcSEcCtD
Procaine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000189	0.00115	CcSEcCtD
Procaine—Nervousness—Ramipril—type 2 diabetes mellitus	0.000188	0.00114	CcSEcCtD
Procaine—Somnolence—Metformin—type 2 diabetes mellitus	0.000185	0.00112	CcSEcCtD
Procaine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000185	0.00112	CcSEcCtD
Procaine—Oedema—Losartan—type 2 diabetes mellitus	0.000185	0.00112	CcSEcCtD
Procaine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000183	0.00111	CcSEcCtD
Procaine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000183	0.00111	CcSEcCtD
Procaine—Tremor—Ramipril—type 2 diabetes mellitus	0.000182	0.0011	CcSEcCtD
Procaine—Shock—Losartan—type 2 diabetes mellitus	0.000182	0.0011	CcSEcCtD
Procaine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000181	0.0011	CcSEcCtD
Procaine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000181	0.0011	CcSEcCtD
Procaine—Tachycardia—Losartan—type 2 diabetes mellitus	0.00018	0.00109	CcSEcCtD
Procaine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00018	0.00109	CcSEcCtD
Procaine—Fatigue—Metformin—type 2 diabetes mellitus	0.000179	0.00109	CcSEcCtD
Procaine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000179	0.00109	CcSEcCtD
Procaine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000179	0.00109	CcSEcCtD
Procaine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000178	0.00108	CcSEcCtD
Procaine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000178	0.00108	CcSEcCtD
Procaine—Agitation—Ramipril—type 2 diabetes mellitus	0.000178	0.00108	CcSEcCtD
Procaine—Angioedema—Ramipril—type 2 diabetes mellitus	0.000177	0.00108	CcSEcCtD
Procaine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000176	0.00107	CcSEcCtD
Procaine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000176	0.00107	CcSEcCtD
Procaine—Rash—Glyburide—type 2 diabetes mellitus	0.000174	0.00106	CcSEcCtD
Procaine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000174	0.00106	CcSEcCtD
Procaine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000174	0.00106	CcSEcCtD
Procaine—Syncope—Ramipril—type 2 diabetes mellitus	0.000174	0.00106	CcSEcCtD
Procaine—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000174	0.00105	CcSEcCtD
Procaine—Hypotension—Losartan—type 2 diabetes mellitus	0.000172	0.00105	CcSEcCtD
Procaine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.00017	0.00104	CcSEcCtD
Procaine—Probenecid—CYP3A4—type 2 diabetes mellitus	0.00017	0.0492	CrCbGaD
Procaine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00017	0.00103	CcSEcCtD
Procaine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000169	0.00103	CcSEcCtD
Procaine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000168	0.00102	CcSEcCtD
Procaine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000168	0.00102	CcSEcCtD
Procaine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000168	0.00102	CcSEcCtD
Procaine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000166	0.00101	CcSEcCtD
Procaine—Urticaria—Metformin—type 2 diabetes mellitus	0.000165	0.001	CcSEcCtD
Procaine—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000165	0.001	CcSEcCtD
Procaine—Anxiety—Ramipril—type 2 diabetes mellitus	0.000165	0.000999	CcSEcCtD
Procaine—Nausea—Glyburide—type 2 diabetes mellitus	0.000164	0.000998	CcSEcCtD
Procaine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000164	0.000998	CcSEcCtD
Procaine—Somnolence—Losartan—type 2 diabetes mellitus	0.000164	0.000997	CcSEcCtD
Procaine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000161	0.000981	CcSEcCtD
Procaine—Pruritus—Orlistat—type 2 diabetes mellitus	0.00016	0.000969	CcSEcCtD
Procaine—Fatigue—Losartan—type 2 diabetes mellitus	0.000159	0.000967	CcSEcCtD
Procaine—Oedema—Ramipril—type 2 diabetes mellitus	0.000158	0.000961	CcSEcCtD
Procaine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000158	0.000961	CcSEcCtD
Procaine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000158	0.000959	CcSEcCtD
Procaine—Rash—Gliclazide—type 2 diabetes mellitus	0.000157	0.000951	CcSEcCtD
Procaine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000156	0.00095	CcSEcCtD
Procaine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000156	0.000948	CcSEcCtD
Procaine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000156	0.000946	CcSEcCtD
Procaine—Shock—Ramipril—type 2 diabetes mellitus	0.000156	0.000946	CcSEcCtD
Procaine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000155	0.000942	CcSEcCtD
Procaine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000155	0.000941	CcSEcCtD
Procaine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000154	0.000938	CcSEcCtD
Procaine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000154	0.000937	CcSEcCtD
Procaine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000153	0.000929	CcSEcCtD
Procaine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000151	0.000917	CcSEcCtD
Procaine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000149	0.000906	CcSEcCtD
Procaine—Probenecid—ALB—type 2 diabetes mellitus	0.000149	0.043	CrCbGaD
Procaine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000148	0.000898	CcSEcCtD
Procaine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000148	0.000896	CcSEcCtD
Procaine—Pruritus—Metformin—type 2 diabetes mellitus	0.000147	0.000893	CcSEcCtD
Procaine—Urticaria—Losartan—type 2 diabetes mellitus	0.000147	0.000891	CcSEcCtD
Procaine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000146	0.000886	CcSEcCtD
Procaine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000145	0.000881	CcSEcCtD
Procaine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000145	0.000878	CcSEcCtD
Procaine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000144	0.000876	CcSEcCtD
Procaine—Rash—Valsartan—type 2 diabetes mellitus	0.000144	0.000874	CcSEcCtD
Procaine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000144	0.000873	CcSEcCtD
Procaine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000143	0.000871	CcSEcCtD
Procaine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000142	0.000864	CcSEcCtD
Procaine—Rash—Orlistat—type 2 diabetes mellitus	0.000142	0.000864	CcSEcCtD
Procaine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000142	0.000863	CcSEcCtD
Procaine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000141	0.000855	CcSEcCtD
Procaine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000139	0.000843	CcSEcCtD
Procaine—Dizziness—Metformin—type 2 diabetes mellitus	0.000137	0.000835	CcSEcCtD
Procaine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000136	0.000829	CcSEcCtD
Procaine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000136	0.000826	CcSEcCtD
Procaine—Nausea—Valsartan—type 2 diabetes mellitus	0.000136	0.000823	CcSEcCtD
Procaine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000134	0.000815	CcSEcCtD
Procaine—Nausea—Orlistat—type 2 diabetes mellitus	0.000134	0.000814	CcSEcCtD
Procaine—BCHE—liver—type 2 diabetes mellitus	0.000133	0.0204	CbGeAlD
Procaine—Vomiting—Metformin—type 2 diabetes mellitus	0.000132	0.000803	CcSEcCtD
Procaine—Rash—Metformin—type 2 diabetes mellitus	0.000131	0.000796	CcSEcCtD
Procaine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000131	0.000795	CcSEcCtD
Procaine—Pruritus—Losartan—type 2 diabetes mellitus	0.000131	0.000793	CcSEcCtD
Procaine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00013	0.000788	CcSEcCtD
Procaine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000126	0.000767	CcSEcCtD
Procaine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000126	0.000764	CcSEcCtD
Procaine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000125	0.00076	CcSEcCtD
Procaine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000125	0.000757	CcSEcCtD
Procaine—Rash—Irbesartan—type 2 diabetes mellitus	0.000124	0.000751	CcSEcCtD
Procaine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000124	0.00075	CcSEcCtD
Procaine—Nausea—Metformin—type 2 diabetes mellitus	0.000123	0.00075	CcSEcCtD
Procaine—Dizziness—Losartan—type 2 diabetes mellitus	0.000122	0.000741	CcSEcCtD
Procaine—Vomiting—Losartan—type 2 diabetes mellitus	0.000117	0.000713	CcSEcCtD
Procaine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000117	0.000708	CcSEcCtD
Procaine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000116	0.000708	CcSEcCtD
Procaine—Rash—Losartan—type 2 diabetes mellitus	0.000116	0.000707	CcSEcCtD
Procaine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000116	0.000706	CcSEcCtD
Procaine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000112	0.00068	CcSEcCtD
Procaine—Nausea—Losartan—type 2 diabetes mellitus	0.00011	0.000666	CcSEcCtD
Procaine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000108	0.000658	CcSEcCtD
Procaine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000105	0.000636	CcSEcCtD
Procaine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000101	0.000611	CcSEcCtD
Procaine—Rash—Ramipril—type 2 diabetes mellitus	9.98e-05	0.000606	CcSEcCtD
Procaine—Dermatitis—Ramipril—type 2 diabetes mellitus	9.97e-05	0.000606	CcSEcCtD
Procaine—Nausea—Ramipril—type 2 diabetes mellitus	9.4e-05	0.000571	CcSEcCtD
Procaine—SCN10A—Developmental Biology—SREBF1—type 2 diabetes mellitus	8.9e-05	0.00181	CbGpPWpGaD
Procaine—BCHE—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	8.73e-05	0.00178	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	8.68e-05	0.00177	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	8.57e-05	0.00175	CbGpPWpGaD
Procaine—CHRNA2—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	8.51e-05	0.00174	CbGpPWpGaD
Procaine—BCHE—Peptide hormone metabolism—INS—type 2 diabetes mellitus	8.44e-05	0.00172	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—TGFBR2—type 2 diabetes mellitus	8.32e-05	0.0017	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	8.28e-05	0.00169	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	8.28e-05	0.00169	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—HMOX1—type 2 diabetes mellitus	8.2e-05	0.00167	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	8.17e-05	0.00167	CbGpPWpGaD
Procaine—BCHE—Peptide hormone metabolism—IGF1—type 2 diabetes mellitus	8.16e-05	0.00166	CbGpPWpGaD
Procaine—SLC6A3—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	8.12e-05	0.00165	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	8.08e-05	0.00165	CbGpPWpGaD
Procaine—CHRNA2—Neuronal System—ADCY5—type 2 diabetes mellitus	8.08e-05	0.00165	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	8.04e-05	0.00164	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	7.99e-05	0.00163	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	7.98e-05	0.00163	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	7.96e-05	0.00162	CbGpPWpGaD
Procaine—SLC6A3—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	7.75e-05	0.00158	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—SLC2A4—type 2 diabetes mellitus	7.72e-05	0.00157	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	7.69e-05	0.00157	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	7.69e-05	0.00157	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—GSTM1—type 2 diabetes mellitus	7.64e-05	0.00156	CbGpPWpGaD
Procaine—SLC6A3—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	7.56e-05	0.00154	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	7.54e-05	0.00154	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	7.46e-05	0.00152	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—AGER—type 2 diabetes mellitus	7.37e-05	0.0015	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	7.35e-05	0.0015	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—ADAMTS9—type 2 diabetes mellitus	7.12e-05	0.00145	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	7.04e-05	0.00144	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	7.04e-05	0.00143	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	7.01e-05	0.00143	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	7.01e-05	0.00143	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	7.01e-05	0.00143	CbGpPWpGaD
Procaine—CHRNA2—Neuronal System—CALM1—type 2 diabetes mellitus	6.94e-05	0.00141	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	6.77e-05	0.00138	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	6.72e-05	0.00137	CbGpPWpGaD
Procaine—BCHE—Neuronal System—SNAP25—type 2 diabetes mellitus	6.69e-05	0.00136	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	6.65e-05	0.00136	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—SNAP25—type 2 diabetes mellitus	6.57e-05	0.00134	CbGpPWpGaD
Procaine—BCHE—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	6.53e-05	0.00133	CbGpPWpGaD
Procaine—CHRNA2—Neuronal System—PRKCB—type 2 diabetes mellitus	6.52e-05	0.00133	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	6.44e-05	0.00131	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	6.41e-05	0.00131	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	6.35e-05	0.00129	CbGpPWpGaD
Procaine—SLC6A3—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	6.29e-05	0.00128	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	6.27e-05	0.00128	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	6.27e-05	0.00128	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	6.25e-05	0.00127	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—LPL—type 2 diabetes mellitus	6.05e-05	0.00123	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	6.04e-05	0.00123	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	6.04e-05	0.00123	CbGpPWpGaD
Procaine—SLC6A3—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	6.03e-05	0.00123	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	5.93e-05	0.00121	CbGpPWpGaD
Procaine—BCHE—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	5.82e-05	0.00119	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—SLC30A8—type 2 diabetes mellitus	5.81e-05	0.00118	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—DPP4—type 2 diabetes mellitus	5.81e-05	0.00118	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	5.8e-05	0.00118	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—CD36—type 2 diabetes mellitus	5.75e-05	0.00117	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	5.71e-05	0.00116	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—GIP—type 2 diabetes mellitus	5.59e-05	0.00114	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	5.55e-05	0.00113	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	5.53e-05	0.00113	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	5.48e-05	0.00112	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	5.48e-05	0.00112	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—PCSK1—type 2 diabetes mellitus	5.4e-05	0.0011	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—PPARA—type 2 diabetes mellitus	5.35e-05	0.00109	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	5.31e-05	0.00108	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	5.31e-05	0.00108	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	5.29e-05	0.00108	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—ST6GAL1—type 2 diabetes mellitus	5.23e-05	0.00107	CbGpPWpGaD
Procaine—BCHE—Metabolism—BHMT—type 2 diabetes mellitus	5.21e-05	0.00106	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	5.13e-05	0.00105	CbGpPWpGaD
Procaine—SLC6A3—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	5.12e-05	0.00104	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—LEP—type 2 diabetes mellitus	5.07e-05	0.00103	CbGpPWpGaD
Procaine—BCHE—Phospholipid metabolism—PIK3R1—type 2 diabetes mellitus	5.02e-05	0.00102	CbGpPWpGaD
Procaine—BCHE—Neuronal System—GNB3—type 2 diabetes mellitus	5e-05	0.00102	CbGpPWpGaD
Procaine—BCHE—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	5e-05	0.00102	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	4.96e-05	0.00101	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	4.95e-05	0.00101	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—GNB3—type 2 diabetes mellitus	4.91e-05	0.001	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	4.91e-05	0.001	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	4.75e-05	0.000969	CbGpPWpGaD
Procaine—BCHE—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	4.7e-05	0.000957	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	4.68e-05	0.000955	CbGpPWpGaD
Procaine—SLC6A3—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	4.61e-05	0.00094	CbGpPWpGaD
Procaine—BCHE—Metabolism—AANAT—type 2 diabetes mellitus	4.55e-05	0.000928	CbGpPWpGaD
Procaine—BCHE—Metabolism—PTGDS—type 2 diabetes mellitus	4.55e-05	0.000928	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	4.46e-05	0.00091	CbGpPWpGaD
Procaine—BCHE—Neuronal System—ADCY5—type 2 diabetes mellitus	4.46e-05	0.000909	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—PPARG—type 2 diabetes mellitus	4.42e-05	0.000901	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—ADCY5—type 2 diabetes mellitus	4.38e-05	0.000892	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—INS—type 2 diabetes mellitus	4.34e-05	0.000884	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	4.33e-05	0.000882	CbGpPWpGaD
Procaine—BCHE—Metabolism—GPD2—type 2 diabetes mellitus	4.32e-05	0.00088	CbGpPWpGaD
Procaine—BCHE—Metabolism—CDO1—type 2 diabetes mellitus	4.32e-05	0.00088	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—MMP9—type 2 diabetes mellitus	4.27e-05	0.000871	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	4.22e-05	0.00086	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	4.19e-05	0.000855	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—AKT2—type 2 diabetes mellitus	4.19e-05	0.000854	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	4.19e-05	0.000854	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	4.12e-05	0.000841	CbGpPWpGaD
Procaine—BCHE—Metabolism—AK1—type 2 diabetes mellitus	4.12e-05	0.000839	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	4.07e-05	0.00083	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—SRC—type 2 diabetes mellitus	3.94e-05	0.000803	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	3.94e-05	0.000803	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	3.94e-05	0.000803	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—ATF3—type 2 diabetes mellitus	3.87e-05	0.00079	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	3.84e-05	0.000783	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—VEGFA—type 2 diabetes mellitus	3.84e-05	0.000782	CbGpPWpGaD
Procaine—BCHE—Neuronal System—CALM1—type 2 diabetes mellitus	3.83e-05	0.000781	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	3.82e-05	0.000779	CbGpPWpGaD
Procaine—BCHE—Metabolism—SLC5A4—type 2 diabetes mellitus	3.8e-05	0.000775	CbGpPWpGaD
Procaine—BCHE—Metabolism—MAT1A—type 2 diabetes mellitus	3.8e-05	0.000775	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	3.8e-05	0.000774	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	3.78e-05	0.000771	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—CALM1—type 2 diabetes mellitus	3.76e-05	0.000766	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	3.71e-05	0.000757	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	3.68e-05	0.00075	CbGpPWpGaD
Procaine—BCHE—Metabolism—PPP1R3C—type 2 diabetes mellitus	3.67e-05	0.000748	CbGpPWpGaD
Procaine—BCHE—Metabolism—HBA2—type 2 diabetes mellitus	3.67e-05	0.000748	CbGpPWpGaD
Procaine—BCHE—Metabolism—ND1—type 2 diabetes mellitus	3.67e-05	0.000748	CbGpPWpGaD
Procaine—BCHE—Metabolism—ENPP1—type 2 diabetes mellitus	3.67e-05	0.000748	CbGpPWpGaD
Procaine—BCHE—Metabolism—G6PC—type 2 diabetes mellitus	3.67e-05	0.000748	CbGpPWpGaD
Procaine—BCHE—Neuronal System—PRKCB—type 2 diabetes mellitus	3.6e-05	0.000734	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—RELA—type 2 diabetes mellitus	3.58e-05	0.000729	CbGpPWpGaD
Procaine—BCHE—Metabolism—GCGR—type 2 diabetes mellitus	3.55e-05	0.000725	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—PRKCB—type 2 diabetes mellitus	3.53e-05	0.00072	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—F7—type 2 diabetes mellitus	3.48e-05	0.000709	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—EGFR—type 2 diabetes mellitus	3.45e-05	0.000704	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	3.42e-05	0.000698	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—PAX6—type 2 diabetes mellitus	3.39e-05	0.00069	CbGpPWpGaD
Procaine—BCHE—Metabolism—CYTB—type 2 diabetes mellitus	3.36e-05	0.000684	CbGpPWpGaD
Procaine—BCHE—Metabolism—OXCT1—type 2 diabetes mellitus	3.36e-05	0.000684	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	3.35e-05	0.000682	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.32e-05	0.000676	CbGpPWpGaD
Procaine—BCHE—Metabolism—SRD5A1—type 2 diabetes mellitus	3.27e-05	0.000667	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	3.19e-05	0.000651	CbGpPWpGaD
Procaine—BCHE—Metabolism—STAR—type 2 diabetes mellitus	3.12e-05	0.000636	CbGpPWpGaD
Procaine—BCHE—Metabolism—HSD17B3—type 2 diabetes mellitus	3.12e-05	0.000636	CbGpPWpGaD
Procaine—BCHE—Metabolism—ACACA—type 2 diabetes mellitus	3.12e-05	0.000636	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—TGFB1—type 2 diabetes mellitus	3.12e-05	0.000635	CbGpPWpGaD
Procaine—SLC6A3—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	3.1e-05	0.000633	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—GHRL—type 2 diabetes mellitus	3.1e-05	0.000632	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.06e-05	0.000624	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—MMP9—type 2 diabetes mellitus	3.05e-05	0.000622	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—NFKB1—type 2 diabetes mellitus	3.02e-05	0.000615	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—ACE—type 2 diabetes mellitus	3e-05	0.000612	CbGpPWpGaD
Procaine—BCHE—Metabolism—CBS—type 2 diabetes mellitus	2.99e-05	0.00061	CbGpPWpGaD
Procaine—BCHE—Metabolism—ABCC8—type 2 diabetes mellitus	2.99e-05	0.00061	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—TCF7L2—type 2 diabetes mellitus	2.88e-05	0.000588	CbGpPWpGaD
Procaine—BCHE—Metabolism—SLC5A2—type 2 diabetes mellitus	2.88e-05	0.000587	CbGpPWpGaD
Procaine—BCHE—Metabolism—COX2—type 2 diabetes mellitus	2.88e-05	0.000587	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—GCG—type 2 diabetes mellitus	2.84e-05	0.000578	CbGpPWpGaD
Procaine—BCHE—Metabolism—NCOA6—type 2 diabetes mellitus	2.83e-05	0.000577	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	2.83e-05	0.000576	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—SRC—type 2 diabetes mellitus	2.81e-05	0.000573	CbGpPWpGaD
Procaine—BCHE—Metabolism—UCP3—type 2 diabetes mellitus	2.78e-05	0.000567	CbGpPWpGaD
Procaine—BCHE—Metabolism—UCP2—type 2 diabetes mellitus	2.78e-05	0.000567	CbGpPWpGaD
Procaine—BCHE—Metabolism—HSD11B1—type 2 diabetes mellitus	2.78e-05	0.000567	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—VEGFA—type 2 diabetes mellitus	2.74e-05	0.000558	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	2.7e-05	0.00055	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—IL6—type 2 diabetes mellitus	2.65e-05	0.000541	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	2.64e-05	0.000538	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	2.63e-05	0.000536	CbGpPWpGaD
Procaine—BCHE—Metabolism—PCK1—type 2 diabetes mellitus	2.62e-05	0.000533	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.6e-05	0.000531	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.57e-05	0.000525	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.52e-05	0.000513	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—TGFB1—type 2 diabetes mellitus	2.51e-05	0.000512	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.51e-05	0.000512	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—EGFR—type 2 diabetes mellitus	2.46e-05	0.000502	CbGpPWpGaD
Procaine—BCHE—Metabolism—HK1—type 2 diabetes mellitus	2.45e-05	0.000499	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.45e-05	0.000499	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—GNB3—type 2 diabetes mellitus	2.44e-05	0.000498	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—IGF2—type 2 diabetes mellitus	2.4e-05	0.000489	CbGpPWpGaD
Procaine—BCHE—Metabolism—LPA—type 2 diabetes mellitus	2.37e-05	0.000482	CbGpPWpGaD
Procaine—BCHE—Metabolism—KCNJ11—type 2 diabetes mellitus	2.37e-05	0.000482	CbGpPWpGaD
Procaine—BCHE—Metabolism—GCKR—type 2 diabetes mellitus	2.37e-05	0.000482	CbGpPWpGaD
Procaine—BCHE—Metabolism—HSD3B2—type 2 diabetes mellitus	2.37e-05	0.000482	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.35e-05	0.000479	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—TNF—type 2 diabetes mellitus	2.35e-05	0.000478	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.27e-05	0.000464	CbGpPWpGaD
Procaine—BCHE—Metabolism—ALDOB—type 2 diabetes mellitus	2.27e-05	0.000462	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.2e-05	0.000449	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.16e-05	0.00044	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.13e-05	0.000435	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.12e-05	0.000433	CbGpPWpGaD
Procaine—BCHE—Metabolism—GLP1R—type 2 diabetes mellitus	2.11e-05	0.00043	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.99e-05	0.000406	CbGpPWpGaD
Procaine—BCHE—Metabolism—SLC2A2—type 2 diabetes mellitus	1.97e-05	0.000401	CbGpPWpGaD
Procaine—BCHE—Metabolism—CPT1A—type 2 diabetes mellitus	1.93e-05	0.000393	CbGpPWpGaD
Procaine—BCHE—Metabolism—MTR—type 2 diabetes mellitus	1.93e-05	0.000393	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—MMP1—type 2 diabetes mellitus	1.93e-05	0.000393	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—AGT—type 2 diabetes mellitus	1.9e-05	0.000388	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—IL6—type 2 diabetes mellitus	1.89e-05	0.000386	CbGpPWpGaD
Procaine—BCHE—Metabolism—NAMPT—type 2 diabetes mellitus	1.89e-05	0.000385	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.88e-05	0.000383	CbGpPWpGaD
Procaine—BCHE—Metabolism—GCK—type 2 diabetes mellitus	1.88e-05	0.000383	CbGpPWpGaD
Procaine—BCHE—Metabolism—LIPC—type 2 diabetes mellitus	1.88e-05	0.000383	CbGpPWpGaD
Procaine—BCHE—Metabolism—HBA1—type 2 diabetes mellitus	1.88e-05	0.000383	CbGpPWpGaD
Procaine—BCHE—Metabolism—CYP11A1—type 2 diabetes mellitus	1.87e-05	0.000381	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—LEP—type 2 diabetes mellitus	1.86e-05	0.00038	CbGpPWpGaD
Procaine—BCHE—Metabolism—SLC9A1—type 2 diabetes mellitus	1.83e-05	0.000374	CbGpPWpGaD
Procaine—BCHE—Metabolism—CETP—type 2 diabetes mellitus	1.81e-05	0.000369	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—AKT1—type 2 diabetes mellitus	1.75e-05	0.000356	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.69e-05	0.000345	CbGpPWpGaD
Procaine—BCHE—Metabolism—PSMD6—type 2 diabetes mellitus	1.69e-05	0.000344	CbGpPWpGaD
Procaine—BCHE—Metabolism—SNAP25—type 2 diabetes mellitus	1.69e-05	0.000344	CbGpPWpGaD
Procaine—BCHE—Metabolism—SREBF1—type 2 diabetes mellitus	1.69e-05	0.000344	CbGpPWpGaD
Procaine—BCHE—Metabolism—CTGF—type 2 diabetes mellitus	1.65e-05	0.000337	CbGpPWpGaD
Procaine—BCHE—Metabolism—HMGCR—type 2 diabetes mellitus	1.64e-05	0.000334	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.62e-05	0.00033	CbGpPWpGaD
Procaine—BCHE—Metabolism—ADRA2A—type 2 diabetes mellitus	1.6e-05	0.000327	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—INS—type 2 diabetes mellitus	1.59e-05	0.000325	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.58e-05	0.000322	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—CCL2—type 2 diabetes mellitus	1.57e-05	0.000319	CbGpPWpGaD
Procaine—BCHE—Metabolism—CYP2E1—type 2 diabetes mellitus	1.54e-05	0.000314	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—IGF1—type 2 diabetes mellitus	1.54e-05	0.000314	CbGpPWpGaD
Procaine—BCHE—Metabolism—SLC2A1—type 2 diabetes mellitus	1.52e-05	0.000311	CbGpPWpGaD
Procaine—BCHE—Metabolism—CYP1A2—type 2 diabetes mellitus	1.52e-05	0.000311	CbGpPWpGaD
Procaine—BCHE—Metabolism—CYP3A4—type 2 diabetes mellitus	1.49e-05	0.000303	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.48e-05	0.000301	CbGpPWpGaD
Procaine—BCHE—Metabolism—SLC2A4—type 2 diabetes mellitus	1.46e-05	0.000298	CbGpPWpGaD
Procaine—BCHE—Metabolism—GCG—type 2 diabetes mellitus	1.46e-05	0.000298	CbGpPWpGaD
Procaine—BCHE—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.26e-05	0.000257	CbGpPWpGaD
Procaine—BCHE—Metabolism—GNB3—type 2 diabetes mellitus	1.26e-05	0.000257	CbGpPWpGaD
Procaine—BCHE—Metabolism—HMOX1—type 2 diabetes mellitus	1.25e-05	0.000256	CbGpPWpGaD
Procaine—BCHE—Metabolism—CAT—type 2 diabetes mellitus	1.24e-05	0.000252	CbGpPWpGaD
Procaine—BCHE—Metabolism—APOB—type 2 diabetes mellitus	1.2e-05	0.000245	CbGpPWpGaD
Procaine—BCHE—Metabolism—GSTM1—type 2 diabetes mellitus	1.17e-05	0.000238	CbGpPWpGaD
Procaine—BCHE—Metabolism—LPL—type 2 diabetes mellitus	1.15e-05	0.000234	CbGpPWpGaD
Procaine—BCHE—Metabolism—ADCY5—type 2 diabetes mellitus	1.12e-05	0.000229	CbGpPWpGaD
Procaine—BCHE—Metabolism—GPX1—type 2 diabetes mellitus	1.12e-05	0.000228	CbGpPWpGaD
Procaine—BCHE—Metabolism—CD36—type 2 diabetes mellitus	1.09e-05	0.000222	CbGpPWpGaD
Procaine—BCHE—Metabolism—PPP2CA—type 2 diabetes mellitus	1.08e-05	0.000219	CbGpPWpGaD
Procaine—BCHE—Metabolism—MTHFR—type 2 diabetes mellitus	1.03e-05	0.00021	CbGpPWpGaD
Procaine—BCHE—Metabolism—PPARA—type 2 diabetes mellitus	1.01e-05	0.000206	CbGpPWpGaD
Procaine—BCHE—Metabolism—AGT—type 2 diabetes mellitus	9.81e-06	0.0002	CbGpPWpGaD
Procaine—BCHE—Metabolism—CALM1—type 2 diabetes mellitus	9.64e-06	0.000197	CbGpPWpGaD
Procaine—BCHE—Metabolism—APOE—type 2 diabetes mellitus	9.61e-06	0.000196	CbGpPWpGaD
Procaine—BCHE—Metabolism—APOA1—type 2 diabetes mellitus	9.5e-06	0.000194	CbGpPWpGaD
Procaine—BCHE—Metabolism—PPARG—type 2 diabetes mellitus	8.37e-06	0.000171	CbGpPWpGaD
Procaine—BCHE—Metabolism—INS—type 2 diabetes mellitus	8.21e-06	0.000167	CbGpPWpGaD
Procaine—BCHE—Metabolism—ALB—type 2 diabetes mellitus	7.53e-06	0.000153	CbGpPWpGaD
Procaine—BCHE—Metabolism—NOS3—type 2 diabetes mellitus	7.2e-06	0.000147	CbGpPWpGaD
Procaine—BCHE—Metabolism—PIK3R1—type 2 diabetes mellitus	7.2e-06	0.000147	CbGpPWpGaD
Procaine—BCHE—Metabolism—PTGS2—type 2 diabetes mellitus	6.59e-06	0.000134	CbGpPWpGaD
Procaine—BCHE—Metabolism—AKT1—type 2 diabetes mellitus	3.31e-06	6.75e-05	CbGpPWpGaD
